Short answer
U S PHYSICAL THERAPY INC /NV (USPH) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Conference call covered Q3 and nine-month results ended September 30, 2026.
U S PHYSICAL THERAPY INC /NV 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Conference call covered Q3 and nine-month results ended September 30, 2026
- Transcript available in Exhibit 99.1, providing management commentary on operating performance
- Investor relevance: supplemental context beyond reported financial statements for USPH's outpatient therapy and industrial injury prevention businesses
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $223M, up 13%, with visits up 8% to 1.68M and revenue per visit up $5 to $111
- Hospital affiliations exceeded $25M revenue, covering 72 clinics, including 62 Metro and 10 Gulf Coast facilities
- Adjusted PT margin 19%, up 60 basis points despite approximately 150 basis points of employee-benefit pressure
- Employee insurance claims expense $7M above last year year-to-date, creating a significant ongoing margin risk
- EBITDA $28M, up $4M, supporting reaffirmed full-year guidance of $102M to $106M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other U S PHYSICAL THERAPY INC /NV 8-K filings
Get the next USPH 8-K as it lands
Follow USPH for push alerts, or ask the research agent what this filing means.